$VIVS

VivoSim Labs, INC.

Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · San Diego, CA

VIVS chart

What traders are saying about $VIVS

Latest posts

VivoSim Labs, INC. news

VivoSim Labs, INC. key financials

USD2025202420232022
Revenue$131,000$144,000$109,000$370,000
Net income-$13.8M-$2.5M-$14.7M-$17.3M
Diluted EPS$-5.35$-1.70$-19.25$-1.98
Total assets (year end)$7.0M$3.8M$8.9M$25.1M
Cash and equivalents (year end)$4.3M$1.2M$5.3M$20.2M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About VivoSim Labs, INC.

Ticker
VIVS (Nasdaq)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
San Diego, CA
Incorporated in
DE
Fiscal year end
March 31
SEC CIK
1497253
Former names
ORGANOVO HOLDINGS, INC., REAL ESTATE RESTORATION & RENTAL, INC.

Frequently asked questions

What exchange is VivoSim Labs, INC. listed on?

VivoSim Labs, INC. trades on the Nasdaq under the ticker symbol VIVS.

What industry is VivoSim Labs, INC. in?

VivoSim Labs, INC. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.

Where is VivoSim Labs, INC. headquartered?

VivoSim Labs, INC.'s business address on file with the SEC is in San Diego, CA.

When does VivoSim Labs, INC.'s fiscal year end?

VivoSim Labs, INC.'s fiscal year ends on March 31.

How much revenue did VivoSim Labs, INC. report?

VivoSim Labs, INC. reported $131,000 in revenue for calendar year 2025, according to its SEC filings.